Jon Hamilton
👤 PersonAppearances Over Time
Podcast Appearances
Ken and Sue knew the drug had risks and was, at best, a stopgap measure.
Ken and Sue knew the drug had risks and was, at best, a stopgap measure.
Ken and Sue knew the drug had risks and was, at best, a stopgap measure.
At first, the drug seemed to help. Sue was able to take a trip to New York.
At first, the drug seemed to help. Sue was able to take a trip to New York.
At first, the drug seemed to help. Sue was able to take a trip to New York.
It was really six girls.
It was really six girls.
It was really six girls.
Even when Sue's memory got worse, the couple kept making the half-hour drive from St. Charles to St. Louis for treatment. In late 2024, I got an update from Ken, but not Sue. I didn't think it would help to have her participate today, honestly. Sue's Alzheimer's had reached the point where the drug was unlikely to help.
Even when Sue's memory got worse, the couple kept making the half-hour drive from St. Charles to St. Louis for treatment. In late 2024, I got an update from Ken, but not Sue. I didn't think it would help to have her participate today, honestly. Sue's Alzheimer's had reached the point where the drug was unlikely to help.
Even when Sue's memory got worse, the couple kept making the half-hour drive from St. Charles to St. Louis for treatment. In late 2024, I got an update from Ken, but not Sue. I didn't think it would help to have her participate today, honestly. Sue's Alzheimer's had reached the point where the drug was unlikely to help.
Sue's experience with Lekembe is pretty typical, says Dr. Joyce Snyder, a neurologist at the Knight Alzheimer Disease Research Center at Washington University.
Sue's experience with Lekembe is pretty typical, says Dr. Joyce Snyder, a neurologist at the Knight Alzheimer Disease Research Center at Washington University.
Sue's experience with Lekembe is pretty typical, says Dr. Joyce Snyder, a neurologist at the Knight Alzheimer Disease Research Center at Washington University.
Snyder says that for all its limitations, Lekembe represents a meaningful change in Alzheimer's treatment.
Snyder says that for all its limitations, Lekembe represents a meaningful change in Alzheimer's treatment.
Snyder says that for all its limitations, Lekembe represents a meaningful change in Alzheimer's treatment.
Some days, though, she has trouble finding her way around her own house. On one of those days, she began asking Ken to move her to a care home. So Ken found one she liked.
Some days, though, she has trouble finding her way around her own house. On one of those days, she began asking Ken to move her to a care home. So Ken found one she liked.